These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35063267)

  • 21. The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy.
    Giles TD; Oparil S; Ofili EO; Pitt B; Purkayastha D; Hilkert R; Samuel R; Sowers JR
    Blood Press Monit; 2011 Apr; 16(2):87-95. PubMed ID: 21386706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study.
    Wright RF; Duprez D; Purkayastha D; Samuel R; Ferdinand KC
    J Clin Hypertens (Greenwich); 2011 Aug; 13(8):588-97. PubMed ID: 21806769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen.
    Hayoz D; Zappe DH; Meyer MA; Baek I; Kandra A; Joly MP; Mazzolai L; Haesler E; Periard D
    J Clin Hypertens (Greenwich); 2012 Nov; 14(11):773-8. PubMed ID: 23126349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telmisartan Plus S-Amlodipine Single-Pill Combination Therapy is Safe and Effective in Patients with Hypertension from Large-Scale Nationwide Surveillance Data in Korea (NOVEL) Study.
    Jo SH; Park SJ; Hong GR; Kim SW; Park CG
    Adv Ther; 2021 Jan; 38(1):304-315. PubMed ID: 33108624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olmesartan/amlodipine: a review of its use in the management of hypertension.
    Kreutz R
    Vasc Health Risk Manag; 2011; 7():183-92. PubMed ID: 21490944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
    Chazova IE; Martynyuk TV
    Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-pill telmisartan and amlodipine: a rational combination for the treatment of hypertension.
    Suárez C
    Drugs; 2011 Dec; 71(17):2295-305. PubMed ID: 22085386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study.
    Cho EJ; Lee HY; Sung KC; Park S; Sohn IS; Park CG; Choi DJ; Ha JW; Ahn YK; Shin J; Hong SJ; Kim SK; Chung WJ; Yoo BS; Hong TJ; Youn HJ; Cho MC; Chae SC; Kim YJ; Kim CJ
    Am J Hypertens; 2019 Sep; 32(10):992-1002. PubMed ID: 31099387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.
    Webster R; Salam A; de Silva HA; Selak V; Stepien S; Rajapakse S; Amarasekara S; Amarasena N; Billot L; de Silva AP; Fernando M; Guggilla R; Jan S; Jayawardena J; Maulik PK; Mendis S; Mendis S; Munasinghe J; Naik N; Prabhakaran D; Ranasinghe G; Thom S; Tisserra N; Senaratne V; Wijekoon S; Wijeyasingam S; Rodgers A; Patel A;
    JAMA; 2018 Aug; 320(6):566-579. PubMed ID: 30120478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
    Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telmisartan plus HCTZ vs. amlodipine plus HCTZ in older patients with systolic hypertension: results from a large ambulatory blood pressure monitoring study.
    Neldam S; Edwards C;
    Am J Geriatr Cardiol; 2006; 15(3):151-60. PubMed ID: 16687967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central blood pressure lowering effect of telmisartan-rosuvastatin single-pill combination in hypertensive patients combined with dyslipidemia: A pilot study.
    Choi J; Sung KC; Ihm SH; Yoon CH; Park SW; Park SH; Kim JY; Kwon SU; Lee HY
    J Clin Hypertens (Greenwich); 2021 Sep; 23(9):1664-1674. PubMed ID: 34384001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial.
    Sharma AM; Bakris G; Neutel JM; Littlejohn TW; Kobe M; Ting N; Ley L
    Clin Ther; 2012 Mar; 34(3):537-51. PubMed ID: 22386829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.
    Ando K; Isshiki M; Takahashi K;
    Hypertens Res; 2009 Sep; 32(9):748-52. PubMed ID: 19590506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study.
    Sarkar G; Gaikwad VB; Sharma A; Halder SK; Kumar DA; Anand J; Agrawal S; Kumbhar A; Kinholkar B; Mathur R; Doshi M; Bachani D; Mehta S
    Adv Ther; 2022 Feb; 39(2):923-942. PubMed ID: 34918194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome.
    Raff U; Walker S; Ott C; Schneider MP; Schmieder RE
    J Clin Hypertens (Greenwich); 2015 Feb; 17(2):98-104. PubMed ID: 25537177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.